Children, caregivers and health workers' perceptions and experiences of the XTEMP-R tool to improve tuberculosis treatment.

ABSTRACT: Treating drug-resistant tuberculosis (DR-TB) in children remains a significant challenge for patients, caregivers, and health systems, despite advances in child-friendly drug formulations. While new formulations offer benefits, their widespread availability is limited, and many exhibit poor palatability. A key strategy to improve administration and mask the taste of paediatric TB medications involves creating extemporaneous suspensions. However, this often requires pharmaceutical services not readily available in high-burden settings. To address this, the Global Alliance for TB Drug Development (TB Alliance) developed XTEMP-R, an inexpensive prototype tool designed to facilitate home-based preparation of liquid TB medication suspensions. This study explored the experiences and perceptions

SUBMITTER: Wademan DT 

PROVIDER: S-EPMC12507288 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature